rotenone has been researched along with Esophageal Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, W; Liang, Q; Liu, H; Liu, W; Yu, X; Zhou, L | 1 |
| Baba, Y; Kato, Y | 1 |
| Bai, ML; Li, HJ; Zhang, LX | 1 |
| Alho, JM; Valtonen, E | 1 |
| Akiyama, S; Dohmitsu, K; Ito, K; Kataoka, M; Kawasaki, S; Kondoh, K; Kurokawa, T; Sugiyama, S; Watanabe, T; Yamauchi, M | 1 |
5 other study(ies) available for rotenone and Esophageal Neoplasms
| Article | Year |
|---|---|
Deguelin, an Aurora B Kinase Inhibitor, Exhibits Potent Anti-Tumor Effect in Human Esophageal Squamous Cell Carcinoma.
Topics: Animals; Apoptosis; Aurora Kinase B; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Mice; Rotenone; Xenograft Model Antitumor Assays | 2017 |
Deguelin, a Novel Anti-Tumorigenic Agent in Human Esophageal Squamous Cell Carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cetuximab; Drug Therapy, Combination; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; G1 Phase Cell Cycle Checkpoints; Humans; Rotenone; Survival Rate | 2017 |
[Effects of deguelin on the proliferation and apoptosis of human esophageal cancer cell Ec-109: an experimental research].
Topics: Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplasms; Humans; Proto-Oncogene Proteins c-bcl-2; Rotenone | 2013 |
Interval estimation of inverse dose-response.
Topics: Adult; Animals; Bias; Biometry; Confidence Intervals; Dose-Response Relationship, Drug; Esophageal Neoplasms; Humans; Incidence; Lethal Dose 50; Lung Neoplasms; Models, Statistical; Pharmacology; Poisson Distribution; Probability; Regression Analysis; Rotenone; Smoking; Software; Toxicology | 1995 |
Polyoxyethylene-modified superoxide dismutase reduces side effects of adriamycin and mitomycin C.
Topics: Animals; Carcinoma, Squamous Cell; Doxorubicin; Drug Screening Assays, Antitumor; Electron Transport; Esophageal Neoplasms; Heart; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria, Heart; Mitomycin; Myocardium; NAD(P)H Dehydrogenase (Quinone); Neoplasm Transplantation; Polyethylene Glycols; Rotenone; Superoxide Dismutase; Tumor Cells, Cultured | 1992 |